NASDAQ:AZTA Azenta - AZTA Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Azenta, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $57.22 -1.08 (-1.85%) (As of 02/6/2023 12:00 AM ET) Add Compare Share Share Today's Range$57.04▼$58.7250-Day Range$54.94▼$62.0752-Week Range$37.61▼$93.39Volume572,880 shsAverage Volume754,149 shsMarket Capitalization$3.95 billionP/E Ratio2.02Dividend YieldN/APrice Target$72.60 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Azenta MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside26.9% Upside$72.60 Price TargetShort InterestHealthy10.48% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.11Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth187.88%From $0.33 to $0.95 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.76 out of 5 starsMedical Sector43rd out of 1,027 stocksSpecial Industry Machinery, Not Elsewhere Classified Industry2nd out of 14 stocks 3.5 Analyst's Opinion Consensus RatingAzenta has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $72.60, Azenta has a forecasted upside of 26.9% from its current price of $57.22.Amount of Analyst CoverageAzenta has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted10.48% of the float of Azenta has been sold short.Short Interest Ratio / Days to CoverAzenta has a short interest ratio ("days to cover") of 8.7.Change versus previous monthShort interest in Azenta has recently decreased by 5.35%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAzenta does not currently pay a dividend.Dividend GrowthAzenta does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AZTA. Previous Next 3.4 News and Social Media Coverage News SentimentAzenta has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Azenta this week, compared to 2 articles on an average week.Search Interest2 people have searched for AZTA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Azenta insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.67% of the stock of Azenta is held by insiders.Percentage Held by Institutions96.42% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Azenta are expected to grow by 187.88% in the coming year, from $0.33 to $0.95 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Azenta is 2.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.38.Price to Earnings Ratio vs. SectorThe P/E ratio of Azenta is 2.02, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 118.76.Price to Book Value per Share RatioAzenta has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Azenta (NASDAQ:AZTA) StockAzenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.Read More Receive AZTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter. Email Address AZTA Stock News HeadlinesFebruary 6, 2023 | finance.yahoo.comAzenta Announces Fiscal 2023 First Quarter Earnings Conference Call and WebcastJanuary 26, 2023 | nasdaq.comFirst Week of February 17th Options Trading For Azenta (AZTA)February 6, 2023 | Investing Trends (Ad)New "Vertical" Technology Solves Solar Power's Major FlawEven conservationists hate conventional solar farms. That's because they take up too much land and can degrade the environment. And let's face it, land is expensive...Fortunately, new groundbreaking tower technology solves solar's #1 drawback. These unique vertical structures not only take up to 90% less land space, but also generate extra electric power.January 24, 2023 | finance.yahoo.comAzenta, Inc. (NASDAQ:AZTA): When Will It Breakeven?January 22, 2023 | uk.finance.yahoo.comAzenta, Inc. (AZTA)January 5, 2023 | benzinga.comAzenta Stock (NASDAQ:AZTA), Quotes and News SummaryJanuary 5, 2023 | finance.yahoo.comAzenta to participate in the 25th Annual Needham Growth ConferenceJanuary 5, 2023 | finance.yahoo.comAzenta to participate in the 41st Annual J.P. Morgan Healthcare ConferenceFebruary 6, 2023 | Wall Street Watch Dogs (Ad)The #1 Energy Stock to BuyThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…January 3, 2023 | msn.comWhat To Know About Evercore ISI Group's Downgrade of AzentaDecember 22, 2022 | finance.yahoo.comShould You Consider Azenta (AZTA) for Investment?December 20, 2022 | finance.yahoo.comHere’s Why Azenta (AZTA) Declined in Q3December 19, 2022 | seekingalpha.comAzenta: Excellence In Life Sciences OfferingsDecember 18, 2022 | finance.yahoo.comMultiple Headwinds Dragged Azenta (AZTA) Stock in Q3November 24, 2022 | nasdaq.comAzenta Enters ASR Agreement With JP Morgan Chase Bank To Repurchase $500 Mln Of StockNovember 23, 2022 | marketwatch.comAzenta Inc. Sets $500 Million Accelerated Stock Buyback >AZTANovember 21, 2022 | finance.yahoo.comAzenta to participate in the 5th Annual Evercore ISI HealthCONx ConferenceNovember 15, 2022 | seekingalpha.comAzenta, Inc. (AZTA) Q4 2022 Earnings Call TranscriptNovember 15, 2022 | finance.yahoo.comAzenta Shares Tick Higher After Q4 Earnings Surpass Estimates, $1.5B Share BuybackNovember 15, 2022 | seekingalpha.comAzenta surges 28% as FQ4 earnings climbs; plans $1.5B stock buyback programNovember 15, 2022 | finance.yahoo.comAzenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of DirectorsNovember 15, 2022 | finance.yahoo.comAzenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase ProgramNovember 9, 2022 | finance.yahoo.comAzenta to participate in the Stephens Annual Investment ConferenceNovember 8, 2022 | finance.yahoo.comAzenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development in LuxembourgNovember 8, 2022 | finance.yahoo.comAzenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and WebcastOctober 29, 2022 | finance.yahoo.comWill Azenta (AZTA) Stock Bounce Back?October 17, 2022 | markets.businessinsider.comAzenta COO Matthew McManus Steps DownSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AZTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter. Email Address AZTA Company Calendar Last Earnings11/14/2022Today2/06/2023Next Earnings (Estimated)2/14/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Special industry machinery, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AZTA CUSIPN/A CIK933974 Webwww.brooks.com Phone(978) 262-2400Fax978-262-2500Employees3,100Year FoundedN/APrice Target and Rating Average Stock Price Forecast$72.60 High Stock Price Forecast$82.00 Low Stock Price Forecast$65.00 Forecasted Upside/Downside+26.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$28.32 Trailing P/E Ratio2.02 Forward P/E Ratio173.39 P/E GrowthN/ANet Income$2.13 billion Net Margins383.23% Pretax Margin-1.79% Return on Equity1.31% Return on Assets1.14% Debt Debt-to-Equity RatioN/A Current Ratio10.67 Quick Ratio10.30 Sales & Book Value Annual Sales$555.50 million Price / Sales7.11 Cash Flow$1.18 per share Price / Cash Flow48.59 Book Value$44.83 per share Price / Book1.28Miscellaneous Outstanding Shares69,050,000Free Float67,901,000Market Cap$3.95 billion OptionableOptionable Beta1.54 Key ExecutivesStephen S. SchwartzPresident, CEO & Executive DirectorRobin VachaSenior Vice President-Global OperationsLindon G. RobertsonChief Financial Officer & Executive Vice PresidentMichael PauloVP, Chief Information & Digital OfficerJason W. JosephSecretary, Senior Vice President & General CounselKey CompetitorsLantheusNASDAQ:LNTHCytokineticsNASDAQ:CYTKPremierNASDAQ:PINCMerit Medical SystemsNASDAQ:MMSICRISPR TherapeuticsNASDAQ:CRSPView All CompetitorsInsiders & InstitutionsRetirement Systems of AlabamaBought 664 shares on 2/6/2023Ownership: 0.143%HM Payson & Co.Bought 21,645 shares on 2/6/2023Ownership: 0.042%Pacer Advisors Inc.Bought 17,633 shares on 2/6/2023Ownership: 0.026%Hills Bank & Trust CoSold 407 shares on 2/6/2023Ownership: 0.014%Fisher Asset Management LLCBought 239,211 shares on 2/3/2023Ownership: 1.675%View All Insider TransactionsView All Institutional Transactions AZTA Stock - Frequently Asked Questions Should I buy or sell Azenta stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AZTA shares. View AZTA analyst ratings or view top-rated stocks. What is Azenta's stock price forecast for 2023? 4 Wall Street analysts have issued 12 month target prices for Azenta's shares. Their AZTA share price forecasts range from $65.00 to $82.00. On average, they predict the company's stock price to reach $72.60 in the next twelve months. This suggests a possible upside of 26.9% from the stock's current price. View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts. How have AZTA shares performed in 2023? Azenta's stock was trading at $58.22 on January 1st, 2023. Since then, AZTA shares have decreased by 1.7% and is now trading at $57.22. View the best growth stocks for 2023 here. When is Azenta's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023. View our AZTA earnings forecast. How were Azenta's earnings last quarter? Azenta, Inc. (NASDAQ:AZTA) released its earnings results on Monday, November, 14th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.10. The company earned $137.57 million during the quarter, compared to analyst estimates of $132.01 million. Azenta had a trailing twelve-month return on equity of 1.31% and a net margin of 383.23%. What guidance has Azenta issued on next quarter's earnings? Azenta issued an update on its first quarter 2023 earnings guidance on Wednesday, December, 14th. The company provided earnings per share (EPS) guidance of $0.08-$0.16 for the period, compared to the consensus EPS estimate of $0.09. The company issued revenue guidance of $175.00 million-$190.00 million, compared to the consensus revenue estimate of $163.00 million. What is Azenta's stock symbol? Azenta trades on the NASDAQ under the ticker symbol "AZTA." Who are Azenta's major shareholders? Azenta's stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (3.44%), Ceredex Value Advisors LLC (2.08%), Conestoga Capital Advisors LLC (1.88%), Fisher Asset Management LLC (1.67%), Stephens Investment Management Group LLC (1.22%) and Natixis Advisors L.P. (0.70%). Insiders that own company stock include Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus. View institutional ownership trends. How do I buy shares of Azenta? Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Azenta's stock price today? One share of AZTA stock can currently be purchased for approximately $57.22. How much money does Azenta make? Azenta (NASDAQ:AZTA) has a market capitalization of $3.95 billion and generates $555.50 million in revenue each year. The company earns $2.13 billion in net income (profit) each year or $28.32 on an earnings per share basis. How many employees does Azenta have? The company employs 3,100 workers across the globe. How can I contact Azenta? Azenta's mailing address is 15 Elizabeth Dr, Chelmsford, Massachusetts 01824-4111. The official website for the company is www.brooks.com. The company can be reached via phone at (978) 262-2400, via email at investor@brooks.com, or via fax at 978-262-2500. This page (NASDAQ:AZTA) was last updated on 2/6/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.